Dr. Geoff Dow – New Clinical Trial for Chronic Babesiosis: Tafenoquine, Malaria Drugs, and Hope for Lyme-Linked Fatigue
Integrative Lyme Solutions with Dr. Karlfeldt

Dr. Geoff Dow – New Clinical Trial for Chronic Babesiosis: Tafenoquine, Malaria Drugs, and Hope for Lyme-Linked Fatigue

2026-02-25
Is chronic babesiosis finally getting the scientific attention it deserves?In this episode of Integrative Lyme Solutions, Dr. K sits down with Dr. Geoff Dow, CEO & President of Sixty Degrees Pharmaceuticals, to discuss a groundbreaking clinical trial targeting chronic babesiosis — a common and often overlooked Lyme co-infection. Originally developed for malaria prevention, the drug Tafenoquine (brand name Kodatef®) is now being studied for its potential to treat persistent Babesia infections and Lyme-related fa...
View more
Comments (3)

More Episodes

All Episodes>>

Get this podcast on your phone, Free

Create Your Podcast In Minutes

  • Full-featured podcast site
  • Unlimited storage and bandwidth
  • Comprehensive podcast stats
  • Distribute to Apple Podcasts, Spotify, and more
  • Make money with your podcast
Get Started
It is Free